Chancellor Jeremy Hunt unveiled exciting news during his Spring Budget speech - AstraZeneca is set to construct a cutting-edge vaccine manufacturing plant in Liverpool, marking a significant £450 million investment.

This strategic move by the pharmaceutical giant solidifies its commitment to advancing health science on British soil. Rumours had been circulating for months, and now, with the confirmation from the Chancellor, the anticipation surrounding AstraZeneca's expansion at its existing Liverpool base has reached new heights.

AstraZeneca's investment aims to elevate its Speke manufacturing site, turning it into a hub for the research, development, and production of vaccines. This development builds upon the site's existing role as a key supplier for the world's leading childhood vaccination program.

One noteworthy aspect of the plan is the commitment to environmental sustainability. The new facility is set to be operationally net zero, with power sourced exclusively from renewable energy. This aligns with AstraZeneca's broader mission to contribute to a more sustainable and resilient future.

Chief executive Sir Pascal Soriot, said:

AstraZeneca’s planned investment would enhance the UK’s pandemic preparedness and demonstrates our ongoing confidence in UK life sciences. We will continue to support the UK in driving innovation and patient access, building on the strong foundations which have been put in place.

In his Budget speech to MPs, Mr Hunt said: “To drive investment we’ve delivered one of the most competitive business tax regimes of any major economy, as part of our plan to help our key industries to grow. Our £108bn Life Sciences sector provides over 300,000 high skilled jobs across the UK and is crucial for the country’s health, wealth and resilience.”

The announcement garnered positive reactions, and Liverpool City Region Metro Mayor Steve Rotheram welcomed the news, stating,

(This is) a vote of confidence from AstraZeneca in the work we’re doing to grow our health and life sciences sector. We’ll continue to nurture our strengths to grow the economy, deliver new investment and jobs for local people and establish ourselves as a global leader.

In conclusion, AstraZeneca's substantial investment in Liverpool marks a significant milestone in the UK's pharmaceutical landscape. As the nation continues to fortify its position in life sciences, this venture promises to contribute not only to economic growth but also to global health resilience. The anticipation is high as the pharmaceutical giant paves the way for innovation and sustainability in the field of vaccine manufacturing.

Source: www.lbndaily.co.uk “Chancellor confirms £450m AstraZeneca expansion” Tony McDonough, Liverpool Business News



If you’re seeking a new opportunity in the Process Sector, contact Hywel Thomas today

01928 248955
Hywel Thomas via LinkedIn

Share This Article